Hypermethylated in Cancer 2 (HIC2) Peptide
HIC2
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP
-
- Antigène Tous les produits HIC2
- HIC2 (Hypermethylated in Cancer 2 (HIC2))
- Origine
- Humain, Souris, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-HIC2 Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- HIC2 (Hypermethylated in Cancer 2 (HIC2))
- Synonymes
- HIC2 Peptide, hic2 Peptide, MGC154932 Peptide, HRG22 Peptide, ZBTB30 Peptide, ZNF907 Peptide, AA409108 Peptide, mKIAA1020 Peptide, zgc:109776 Peptide, HIC ZBTB transcriptional repressor 2 Peptide, hypermethylated in cancer 2 L homeolog Peptide, hypermethylated in cancer 2 Peptide, HIC2 Peptide, hic2.L Peptide, Hic2 Peptide, hic2 Peptide
- Sujet
- HRG22, KIAA1020, ZBTB30, Hypermethylated in cancer 2 protein, Hic-2, HIC1-related gene on chromosome 22 protein, Hic-3, Zinc finger and BTB domain-containing protein 30
- ID gène
- 23119, 58180
- UniProt
- Q96JB3, Q9JLZ6
-
Vous êtes ici:
